PTGS2 and cancer: Prostaglandin-endoperoxide synthase 2 (PTGS2), also known as cyclooxygenase-2 (COX-2), mediates resistance by fostering an immunosuppressive microenvironment [55], promoting angiogenesis [55,56], and supporting cancer stem cell populations [57].